Carbamic acid, N-[2-methoxy-4-(4-morpholinyl)-5-nitrophenyl]-, 1,1-dimethylethyl ester
CAS2226199-40-0
Carbamic acid, N-[2-methoxy-4-(4-morpholinyl)-5-nitrophenyl]-, 1,1-dimethylethyl ester (CAS 2226199-40-0) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
![Chemical structure of Carbamic acid, N-[2-methoxy-4-(4-morpholinyl)-5-nitrophenyl]-, 1,1-dimethylethyl ester](https://chemsigma.com/chemicalStructure/22/2226199-40-0.png)
- CAS No.
- 2226199-40-0
Chemical Specifications
Identifiers
| CAS number | 2226199-40-0 |
|---|---|
| Product name | Carbamic acid, N-[2-methoxy-4-(4-morpholinyl)-5-nitrophenyl]-, 1,1-dimethylethyl ester |
| Chinese name | 拉泽替尼 |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of Carbamic acid, N-[2-methoxy-4-(4-morpholinyl)-5-nitrophenyl]-, 1,1-dimethylethyl ester?
The CAS Registry Number of Carbamic acid, N-[2-methoxy-4-(4-morpholinyl)-5-nitrophenyl]-, 1,1-dimethylethyl ester is 2226199-40-0.
How can I request a quotation for Carbamic acid, N-[2-methoxy-4-(4-morpholinyl)-5-nitrophenyl]-, 1,1-dimethylethyl ester?
Send an inquiry for Carbamic acid, N-[2-methoxy-4-(4-morpholinyl)-5-nitrophenyl]-, 1,1-dimethylethyl ester (CAS 2226199-40-0) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for Carbamic acid, N-[2-methoxy-4-(4-morpholinyl)-5-nitrophenyl]-, 1,1-dimethylethyl ester
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.